Australian researchers make powerful, tiny artificial muscles inspired by DNA “supercoiling”
University of Wollongong researchers have developed a new type of DNA-inspired artificial muscle, with potential applications in miniature robotics.
University of Wollongong researchers have developed a new type of DNA-inspired artificial muscle, with potential applications in miniature robotics.
In this part of our Fibres and composites transforming industry series, Innovync looks at carbon fibre, including how it’s made, its history, how it’s being used in Australia.
Anteotech to raise $16 million to fund Covid test Surface chemistry group Anteotech has received commitments from sophisticated investors to raise $12 million in new capital, and now plans a $4 million share purchase plan from existing shareholders. The company, best known for its nano-coating technology for battery lithium, will use the proceeds to scale…
Electronic warfare group DEWC Systems and rocket manufacturer Gilmour Space Technologies are to collaborate to build prototype satellites equipped with electronic warfare payloads.
Research and market development of value-added metals is bearing fruit with Lepidico and Australian Vanadium (AVL) both reporting new company milestones. Today resources and chemicals group Australian Vanadium confirmed positive results from its Cooperative Research Centre CRC-P grant studying the production of value-added vanadium chemicals. Also today lithium chemicals company Lepidico announced it was negotiating…
In May 1926, the Australian inventor of the Sunshine Harvester, Hugh McKay, died. His homegrown invention had created the largest factory in Australia at the time, peaking at 3,000 workers, and transformed Australian agriculture.
Mohammad Alhawamdeh, Omar Alajarmeh, Tristan Shelley, Xuesen Zeng, Peter Schubel explain pultrusion, its usefulness and its growth in adoption in this installment of our Fibres and composites transforming industry series.
Pharmaceutical developer Starpharma has reported its strong financial position and progress on numerous R&D fronts over the March quarter as it accelerates research and commercialisation of its drug portfolio. The Melbourne company spent $4.3 million on R&D in the quarter as well as manufacturing expenses, ending with a closing cash balance of $64.3 million. Net…
Molecular diagnostic company Genetic Signatures has reported year to date sales of $23 million for the nine months to March 31, more than double its full year revenue in the previous financial year. Third quarter sales were $4.3 million including instrument sales of $300,000, up 136 per cent on the previous corresponding period. The company…
The Queensland government diverted up to a third of its industry attraction program to support existing local manufacturers to pivot to COVID-19 supplies, including ventilators, masks and testing kits in the state.